Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 3/20 | 0.68 |
| ▸ | SCN2A | Q99250 | 5/20 | 0.61 |
| ▸ | SCN10A | Q9Y5Y9 | 5/20 | 0.61 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 1/20 | 0.55 |
| ▸ | ABL1 | P00519 | 2/20 | 0.55 |
| ▸ | BCR | P11274 | 2/20 | 0.55 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.55 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.55 |
| ▸ | PRKCA | P17252 | 1/20 | 0.55 |
| ▸ | BRAF | P15056 | 1/20 | 0.50 |
| ▸ | GRM5 | P41594 | 2/20 | 0.49 |
| ▸ | SRC | P12931 | 1/20 | 0.49 |
| ▸ | PRKDC | P78527 | 1/20 | 0.49 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.49 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.49 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.48 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16489055 | 0.86 | ATR (0.65) | ATRSCN2ASCN10AGRM4BRAF | |
| SCHEMBL16420805 | 0.83 | ATR (0.66) | ATRSCN2ASCN10AABL1BCR | |
| SCHEMBL16420803 | 0.82 | IRAK4 (0.63) | ATRSCN2ASCN10AABL1BCR | |
| SCHEMBL1792836 | 0.82 | ATR (0.59) | ATRGRM4PPARGABL1BCR | |
| SCHEMBL2483560 | 0.81 | ATR (1.00) | ATRPRKDC | |
| SCHEMBL16489075 | 0.81 | ATR (0.69) | ATRSCN2ASCN10AABL1BCR | |
| SCHEMBL16420800 | 0.81 | SCN2A (0.54) | ATRSCN2ASCN10AABL1BCR | |
| SCHEMBL14082560 | 0.81 | CYP11B2 (0.65) | ATRGRM4PPARGABL1BCR | |
| SCHEMBL16420804 | 0.80 | IRAK4 (0.69) | ATRSCN2ASCN10AGRM4BRAF | |
| SCHEMBL16489076 | 0.80 | ATR (0.68) | ATRSCN2ASCN10AABL1BCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160311809-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2016-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160311809-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | ATR, CHEK1, MAP3K5 | ATR 1/4885SCN2A 2823/4885SCN10A 4295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.